These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 1825621)
1. Potentiation of medroxyprogesterone acetate antineoplastic activity by histidine in rat mammary tumours. Di Carlo F; Conti G; Giubertoni M; Muccioli G; Racca S Cancer Chemother Pharmacol; 1991; 27(4):271-7. PubMed ID: 1825621 [TBL] [Abstract][Full Text] [Related]
2. High tumour prolactin receptor content and lack of increase in serum prolactin levels as predictors of good response to endocrine therapy in rat mammary cancer. Di Carlo F; Muccioli G; Bellussi G; Conti G; Racca S Int J Cancer; 1988 May; 41(5):767-70. PubMed ID: 2966772 [TBL] [Abstract][Full Text] [Related]
3. Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma. Zanardi S; De Menech R; Pino G; Guarneri D; Dandolo G; Sanguineti M; Moro MG; Barbi GP; Paganuzzi M; Boccardo F Chemioterapia; 1985 Jun; 4(3):239-42. PubMed ID: 3161642 [TBL] [Abstract][Full Text] [Related]
4. Additive inhibitory effects of bromocryptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz[a]anthracene (DMBA)-induced mammary tumors in the rat. Dauvois S; Spinola PG; Labrie F Eur J Cancer Clin Oncol; 1989 May; 25(5):891-7. PubMed ID: 2525471 [TBL] [Abstract][Full Text] [Related]
5. [Combined therapies with medroxyprogesterone acetate (MPA) in DMBA-induced rat mammary cancer]. Ishikawa H; Iino Y; Izuo M; Takikawa H Gan No Rinsho; 1986 Feb; 32(2):151-5. PubMed ID: 2937941 [TBL] [Abstract][Full Text] [Related]
6. Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors. Iino Y; Ishikawa H; Izuo M; Takikawa H Jpn J Clin Oncol; 1989 Mar; 19(1):45-50. PubMed ID: 2522157 [TBL] [Abstract][Full Text] [Related]
7. Effective sequential administration of tamoxifen and medroxyprogesterone acetate for 7,12-dimethylbenz[a-anthracene-induced rat mammary tumors in relation to hormone receptors. Tominaga T; Yoshida Y; Kitamura M; Kosaki G Jpn J Cancer Res; 1985 Nov; 76(11):1120-5. PubMed ID: 2935517 [TBL] [Abstract][Full Text] [Related]
8. Combined and sequential treatment using FCE 21336, a new prolactin-lowering drug, and medroxyprogesterone acetate (MPA) in DMBA-induced tumors in rats. Zaccheo T; Casazza AM; di Salle E; Pollini C; di Marco A Eur J Cancer Clin Oncol; 1984 Sep; 20(9):1193-7. PubMed ID: 6236980 [TBL] [Abstract][Full Text] [Related]
9. Reduction of estrogen and prolactin receptors in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor by high doses of estrogen. Shigaki N; Kimura M; Takano S; Fujino N; Akagi M Jpn J Surg; 1987 Sep; 17(5):395-401. PubMed ID: 3123757 [TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of combination toremifene and medroxyprogesterone acetate (MPA) in vitro and in vivo. Kangas L; Grönroos M J Steroid Biochem; 1990 Jun; 36(3):253-7. PubMed ID: 2142248 [TBL] [Abstract][Full Text] [Related]
11. Effects of medroxyprogesterone acetate on serum prolactin levels and liver prolactin binding capacity in the rat. Muccioli G; Racca S; Ricci Gamalero S; Di Carlo F Pharmacol Res Commun; 1988 Aug; 20(8):719-30. PubMed ID: 3212009 [TBL] [Abstract][Full Text] [Related]
13. Mammary adenocarcinomas induced by medroxyprogesterone acetate: hormone dependence and EGF receptors of BALB/c in vivo sublines. Lanari C; Kordon E; Molinolo A; Pasqualini CD; Charreau EH Int J Cancer; 1989 May; 43(5):845-50. PubMed ID: 2523869 [TBL] [Abstract][Full Text] [Related]
14. Effects of medroxyprogesterone acetate on DMBA-induced mammary tumors. Racca S; Conti G; Crispino A; Gallo E; Di Carlo F Chemioterapia; 1985 Jun; 4(3):236-8. PubMed ID: 3928182 [TBL] [Abstract][Full Text] [Related]
15. Effects of long-term administration of high doses of medroxyprogesterone acetate on hormone receptors and target organs in the female rat. Di Carlo F; Racca S; Conti G; Gallo E; Muccioli G; Sapino A; Bussolati G J Endocrinol; 1984 Dec; 103(3):287-93. PubMed ID: 6094695 [TBL] [Abstract][Full Text] [Related]
16. Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats. Winneker RC; Parsons JA Cancer Res; 1981 May; 41(5):1772-7. PubMed ID: 7214344 [TBL] [Abstract][Full Text] [Related]
17. Grwoth hormone, prolactin, and cortisol in dogs developing mammary nodules and an acromegaly-like appearance during treatment with medroxyprogesterone acetate. Concannon P; Altszuler N; Hampshire J; Butler WR; Hansel W Endocrinology; 1980 Apr; 106(4):1173-7. PubMed ID: 6444575 [TBL] [Abstract][Full Text] [Related]
18. Steroid hormone receptors and response to high-dose medroxyprogesterone acetate in advanced breast cancer. Nomura Y; Tashiro H; Hisamatsu K; Shinozuka K Anticancer Res; 1988; 8(4):647-51. PubMed ID: 2972248 [TBL] [Abstract][Full Text] [Related]
19. Angiogenic activity of rat mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene and its inhibition by medroxyprogesterone acetate: possible involvement of antiangiogenic action of medroxyprogesterone acetate in its tumor growth inhibition. Oikawa T; Hiragun A; Yoshida Y; Ashino-Fuse H; Tominaga T; Iwaguchi T Cancer Lett; 1988 Dec; 43(1-2):85-92. PubMed ID: 2462464 [TBL] [Abstract][Full Text] [Related]
20. Mouse mammary tumors induced by medroxyprogesterone acetate: immunohistochemistry and hormonal receptors. Molinolo AA; Lanari C; Charreau EH; Sanjuan N; Pasqualini CD J Natl Cancer Inst; 1987 Dec; 79(6):1341-50. PubMed ID: 2826865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]